Zimmer Biomet Holdings (ZBH) Cash from Financing Activities (2009 - 2026)

Zimmer Biomet Holdings has reported Cash from Financing Activities for 18 years, with the latest figure at -$271.1 million in Q2 2026.

• On a quarterly basis, Cash from Financing Activities fell 265.51% year-over-year to -$271.1 million in Q2 2026; TTM through Jun 2026 was -$1.1 billion, a 365.57% decrease from a year earlier, with the FY2025 full-year figure at $326.0 million, up 167.29% from the prior year.
• Cash from Financing Activities was -$271.1 million for Q2 2026 at Zimmer Biomet Holdings, up from -$369.2 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $575.4 million in Q1 2025, with the low at -$897.0 million in Q4 2025.
• Average Cash from Financing Activities over 5 years is -$129.9 million, with a median of -$170.0 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Cash from Financing Activities plunged 415.9% in 2022, then jumped 1248.5% in 2025.
• Over 5 years, Cash from Financing Activities stood at -$313.4 million in 2022, then climbed by 19.78% to -$251.4 million in 2023, then climbed by 4.3% to -$240.6 million in 2024, then tumbled by 272.82% to -$897.0 million in 2025, then soared by 69.78% to -$271.1 million in 2026.
• The last three Cash from Financing Activities figures came in at -$271.1 million (Q2 2026), -$369.2 million (Q1 2026), and -$897.0 million (Q4 2025), per Business Quant data.